Joanna Sweeting is a cardiologist based in Sydney, NSW, Australia.
She looks after people with heart conditions where the details really matter, especially long-term heart muscle problems. This can include hypertrophic cardiomyopathy (HCM), familial hypertrophic cardiomyopathy, and cardiomyopathy more broadly. At times, she also sees patients who’ve had serious heart rhythm events, such as cardiac arrest and ventricular fibrillation, where getting the right plan early can make a big difference.
Joanna also has experience working with families and patients linked to genetic and connective tissue conditions that can affect the heart. For example, Marfan syndrome can come with heart changes, and care needs to be steady and well followed over time.
In many cases, the work starts with listening closely to symptoms and history, then putting them together with scans, tests, and other results. People can feel worried when they’re told they have a heart muscle condition or a family-related risk. Joanna’s approach is usually calm and practical, focusing on what’s happening, what to watch for, and how to manage it day to day.
Even when someone feels okay, some heart conditions still need ongoing monitoring. That might mean checking for changes, reviewing medicines, and talking through lifestyle and activity choices. If there’s been a past cardiac event, the goals are often about keeping risks lower and supporting safer long-term care.
Her service also connects with the bigger picture of heart health. Conditions like HCM and related disorders often affect more than one part of the heart and can show up differently from person to person. So the plan may need to be tailored, reviewed, and adjusted as new information comes in.
Experience details aren’t listed here, but Joanna is a cardiologist working in Sydney and dealing with the conditions shown above. Education details aren’t listed here either.
There’s no specific research or clinical trials information provided for Joanna Sweeting. If clinical trials are relevant for a particular patient, it’s usually best to discuss that directly with the treating team to see what options might fit.
